Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Bruce Kramer, M.D.

Co-Author

This page shows the publications co-authored by Daniel Kramer and Peter Zimetbaum.
Connection Strength

4.863
  1. Conversion, Compromise, and Conversation-Moving to a Sensible Middle When Addressing Implantable Cardioverter-Defibrillator Therapy-Reply. JAMA Cardiol. 2019 10 01; 4(10):1049-1050.
    View in: PubMed
    Score: 0.837
  2. Facilitating Conversion of Implantable Cardioverter-Defibrillator Therapy to Pacing Only-Time to Adapt. JAMA Cardiol. 2019 05 01; 4(5):401-402.
    View in: PubMed
    Score: 0.813
  3. Editorial Commentary: Hard questions for mobile technology in cardiology. Trends Cardiovasc Med. 2016 May; 26(4):387-8.
    View in: PubMed
    Score: 0.649
  4. Ectopy and expectations: can we predict atrial fibrillation, and should we try? Ann Intern Med. 2013 Dec 03; 159(11):787-8.
    View in: PubMed
    Score: 0.559
  5. Time for a change--a new approach to ICD replacement. N Engl J Med. 2012 Jan 26; 366(4):291-3.
    View in: PubMed
    Score: 0.492
  6. Long-QT syndrome. Cardiol Rev. 2011 Sep-Oct; 19(5):217-25.
    View in: PubMed
    Score: 0.478
  7. Clinical management of conduction abnormalities following transcatheter aortic valve replacement: prospective evaluation of a standardized management pathway. J Interv Card Electrophysiol. 2022 Feb 25.
    View in: PubMed
    Score: 0.247
  8. A Review of Cardiac Implantable Electronic Device Infections for the Practicing Electrophysiologist. JACC Clin Electrophysiol. 2021 06; 7(6):811-824.
    View in: PubMed
    Score: 0.235
  9. Effect of Smaller Left Ventricular Capture Threshold Safety Margins to Improve Device Longevity in Recipients of Cardiac Resynchronization-Defibrillation Therapy. Am J Cardiol. 2015 Jul 01; 116(1):85-7.
    View in: PubMed
    Score: 0.153
  10. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. Heart Rhythm. 2014 Feb; 11(2):216-21.
    View in: PubMed
    Score: 0.141
  11. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):488-97.
    View in: PubMed
    Score: 0.135
  12. Cost-Effectiveness of Antibiotic-Eluting Envelope for Prevention of Cardiac Implantable Electronic Device Infections in Heart Failure. Circ Cardiovasc Qual Outcomes. 2022 Mar; 15(3):e008443.
    View in: PubMed
    Score: 0.062
  13. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013 Jul 23; 62(4):300-5.
    View in: PubMed
    Score: 0.033
  14. Cardiac resynchronization therapy for low-flow, low-gradient aortic stenosis. Eur J Heart Fail. 2010 Aug; 12(8):889-92.
    View in: PubMed
    Score: 0.027
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.